Relmada Therapeutics (RLMD) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist

0.270
-0.010-3.50%

Close Feb 26 16:00 ET

8.15MMarket Cap-0.09P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Asarina Pharma AB (Publ) - Signs Asset Purchase Agreement With Relmada Therapeutics
ReutersFeb 7 02:30 ET
Mizuho Securities Downgrades Relmada Therapeutics(RLMD.US) to Hold Rating, Cuts Target Price to $1
Moomoo NewsFeb 6 20:31 ET · Ratings
12 Health Care Stocks Moving In Thursday's Pre-Market Session
BenzingaFeb 6 16:05 ET
Relmada Therapeutics Acquires Tourette Syndrome Treatment Candidate, Sepranolone, From Asarina Pharma AB
BenzingaFeb 6 07:34 ET
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome From Asarina Pharma AB
GlobeNewswireFeb 6 07:30 ET
Relmada Therapeutics Acquires Sepranolone for CNS Portfolio
TipRanksFeb 6 07:06 ET

Comments

$Relmada Therapeutics (RLMD.US)$ Why not yet announce delisting or reverse split?

Is it worth keeping or moment to sell?

$Relmada Therapeutics (RLMD.US)$ keeps falling and falling

$Relmada Therapeutics (RLMD.US)$ Everyday new historical low, this shxt just so dead, whoever bought this is fking unlucky.

1

$Relmada Therapeutics (RLMD.US)$ New historical low as expected, this garbage should just delist.

2

1

$Relmada Therapeutics (RLMD.US)$ Multiple analyst have this ranged from $8 to $29 PPS. crazy.

Read more